David Stein

Company: Regeneron Pharmaceuticals Inc

Job title: Director, Medical Operations

Seminars:

Navigating & Successfully Setting Up an Expanded Access Program for an Ultrarare Disease 3:30 pm

• How do you handle an ultrarare disease? • How do you get drugs into countries without well-defined regulations • How do you proceed with continuing a drug within this disease post FDA approval in different countries?Read more

day: Day Two